Literature DB >> 26193647

Rapid progression of Epstein-Barr-virus-positive gastric diffuse large B-cell lymphoma during chemoradiotherapy: a case report.

Tomonori Sumida1, Yasuhiko Kitadai2, Hiroshi Masuda1, Kei Shinagawa1, Miwako Tanaka1, Michiyo Kodama1, Tsuyoshi Kuroda1, Toru Hiyama3, Shinji Tanaka4, Hirofumi Nakayama5, Masaharu Yoshihara3, Tadashi Yoshino6, Kazuaki Chayama1.   

Abstract

A 61-year-old woman was referred to our hospital with epigastralgia and appetite loss. Barium examination and upper gastrointestinal endoscopy revealed uneven erythematous mucosa with multiple elevated lesions from the gastric fornix to the upper corpus. Abdominal computed tomography showed thickening of the wall of the fornix and swelling of perigastric lymph nodes, but whole-body gallium scintigraphy and bone marrow examination did not indicate further involvement. Biopsy specimens showed diffuse infiltration of large atypical lymphoid cells in which Epstein-Barr virus (EBV) was detected by in situ hybridization. Diffuse large B-cell lymphoma (DLBCL), stage II1, was diagnosed. Combination chemotherapy [cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP)], was given, and this was followed by radiotherapy. Partial remission was achieved by chemotherapy, but the disease progressed rapidly during radiotherapy. Because the reported prognosis of EBV-positive DLBCL is unfavorable, the therapeutic strategy for EBV-positive gastric DLBCL should be considered carefully.

Entities:  

Keywords:  Chemoradiotherapy; Diffuse large B-cell lymphoma; Epstein-Barr virus

Year:  2008        PMID: 26193647     DOI: 10.1007/s12328-008-0020-5

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  16 in total

1.  Epstein-Barr virus DNA quantitation assessed by a real-time polymerase chain reaction in a case of Burkitt's lymphoma.

Authors:  J Solassol; K A Kreuzer; U Lass; C A Schmidt
Journal:  Leuk Lymphoma       Date:  2001-05

2.  Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II, diffuse large B-cell lymphoma of the stomach.

Authors:  Satoshi Ishikura; Kensei Tobinai; Atsushi Ohtsu; Shigeo Nakamura; Tadashi Yoshino; Ichiro Oda; Toshiyuki Takagi; Kiyomi Mera; Yoshikazu Kagami; Kuniaki Itoh; Yoshio Tamaki; Junji Suzumiya; Masafumi Taniwaki; Seiichiro Yamamoto
Journal:  Cancer Sci       Date:  2005-06       Impact factor: 6.716

3.  Total gastrectomy for primary gastric lymphoma at stages IE and IIE: a prospective study of fifty cases.

Authors:  T Sano; M Sasako; T Kinoshita; H Katai; K Maruyama; T Takenaka; Y Nakanishi
Journal:  Surgery       Date:  1997-05       Impact factor: 3.982

4.  Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation.

Authors:  J W van Esser; H G Niesters; S F Thijsen; E Meijer; A D Osterhaus; K C Wolthers; C A Boucher; J W Gratama; L M Budel; B van der Holt; A M van Loon; B Löwenberg; L F Verdonck; J J Cornelissen
Journal:  Br J Haematol       Date:  2001-06       Impact factor: 6.998

5.  Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study.

Authors:  Ruth F Jarrett; Gail L Stark; Jo White; Brian Angus; Freda E Alexander; Andrew S Krajewski; June Freeland; G Malcolm Taylor; Penelope R A Taylor
Journal:  Blood       Date:  2005-06-07       Impact factor: 22.113

6.  EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphoma.

Authors:  Pin-Pen Hsieh; Chun-Liang Tung; Amy Bik-Wan Chan; Jia-Bin Liao; Jyh-Seng Wang; Hui-Hwa Tseng; Hsing-Hao Su; Kun-Chao Chang; Chung-Che Chang
Journal:  Am J Clin Pathol       Date:  2007-10       Impact factor: 2.493

7.  Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.

Authors:  T P Miller; S Dahlberg; J R Cassady; D J Adelstein; C M Spier; T M Grogan; M LeBlanc; S Carlin; E Chase; R I Fisher
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

Review 8.  Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target.

Authors:  Huai-Chia Chuang; Jong-Ding Lay; Wen-Chuan Hsieh; Ih-Jen Su
Journal:  Cancer Sci       Date:  2007-07-11       Impact factor: 6.716

9.  The role of surgery in primary gastric lymphoma: results of a controlled clinical trial.

Authors:  Agustin Avilés; M Jesús Nambo; Natividad Neri; Judith Huerta-Guzmán; Ivonne Cuadra; Isabel Alvarado; Claudia Castañeda; Raúl Fernández; Martha González
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

10.  Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.

Authors:  Takashi Oyama; Koichi Ichimura; Ritsuro Suzuki; Junji Suzumiya; Koichi Ohshima; Yasushi Yatabe; Takio Yokoi; Masaru Kojima; Yoshikazu Kamiya; Hirofumi Taji; Yoshitoyo Kagami; Michinori Ogura; Hidehiko Saito; Yasuo Morishima; Shigeo Nakamura
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.